NYSE$KVUE

Kenvue Inc · Q4 2023 earnings

Q4 2023 earnings · · Before market open · Investor relations

Briefing

Kenvue's Q4 2023 results were announced, with net sales decreasing by (2.7)% and diluted earnings per share at $0.17.

Kenvue reported a decrease in net sales by (2.7)% to $3.7 billion with organic growth declining by (2.4)% in Q4 2023. Diluted earnings per share stood at $0.17, while adjusted diluted earnings per share was $0.31.

  • Net sales decreased by (2.7)% to $3.7 billion with organic growth declining by (2.4)%.
  • Diluted earnings per share was $0.17; adjusted diluted earnings per share was $0.31.
  • Gross profit margin increased to 55.7% compared to 54.3% in the prior year period.
  • Adjusted operating income margin was 21.8% versus 19.9% in the prior year period.

Headline financials

Total Revenue

$3.67B

Previous: $15.1B-75.6%
EPS (adj)

$0.31

Previous: $1.21-74.4%
Organic Sales Growth

-2.4%

Previous: 6.2%-138.7%
Organic Volume Growth

-8.2%

No prior period
Organic Price/Mix Growth

5.8%

No prior period
Capital Expenditures

$223M

Previous: $295M-24.4%
Net Income

$327M

Previous: $2.08B-84.3%
Operating Income

$460M

Previous: $2.92B-84.2%
Gross Profit

$2.04B

Previous: $8.42B-75.7%
Stock-Based Comp

$113M

Previous: $141M-19.9%

Revenue & EPS history

Kenvue · Revenue · Quarterly

$3.67B

Q4 2023-75.6%vs Q4 2022
Beat estimate in 7 of 12 quarters(58%)
ActualEstimate

Revenue by segment

Kenvue · $3.92B total across 3 segments · Q3 2023

  • Self Care
    $1.61B+6.4%
  • Essential Health
    $1.18B+3.0%
  • Skin Health & Beauty
    $1.12B-0.4%

Forward guidance

Kenvue expects full year 2024 reported Net sales growth to be in the range of 1.0%to 3.0%.

Tailwinds

  • Net sales growth to be in the range of 1.0%to 3.0%.
  • Foreign exchange is expected to be a headwind of approximately one percentage point to reported Net sales growth.
  • Organic growth in the range of 2.0% to 4.0% with Organic growth sequentially improving as the year progresses as prior year comparisons ease
  • Impact of 2024 strategic priorities take hold
  • Adjusted diluted earnings per share to be in the range of $1.10 - $1.20.

Headwinds

  • Potential for a continued challenging macro-back drop
  • Possibility for unknowns in seasonal businesses
  • Adjusted operating income margin to be slightly below 2023
  • Impact of absorbing a full year of public company costs
  • 50 basis points of foreign currency headwinds

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 13 quarterly earnings reports · overlaid with Q4 2023

Historical avgQ4 2023

+2.0%

Avg return

Earnings day

+3.1%

Avg return

5 days after

+2.8%

Avg return

30 days after

57%

8 / 14 earnings

Positive

+15.7%

Q3 2025

Best reaction

-7.7%

Q3 2023

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+2.0%-1.2%+0.2%
Q4 2025+0.9%+2.9%-5.5%
Q3 2025+15.7%+17.5%+18.1%
Q2 2025+1.5%+2.1%-13.2%
Q1 2025+4.3%+2.4%-6.0%
Q4 2024-4.5%+0.8%+12.9%
Q3 2024+5.2%+5.1%+1.5%
Q2 2024+13.4%+15.6%+23.7%
Q1 2024+7.2%+7.7%-2.4%
Q4 2022-0.2%+3.1%+12.9%
Q4 2023-5.8%-6.2%-2.4%
Q3 2023-7.7%-5.7%+2.6%
Q2 2023-4.0%+0.5%-8.5%
Q1 2023-0.5%-0.8%+4.5%
Q3 2022
Q2 2022
Q1 2022
Q4 2021

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro